This inventor holds 1 USPTO granted patent and 5 published patent applications. Top assignee: The General Hospital Corporation. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: Reinier Johan De Vries: Innovator in Cryopreservation
Introduction
Reinier Johan De Vries is a notable inventor based in Boston, MA. He has made significant contributions to the field of cryopreservation, particularly in the preservation of biological samples, organs, and organisms. His innovative approach has the potential to enhance the viability of preserved biological materials.
Latest Patents
Reinier holds a patent for "High subzero cryopreservation." This patent is centered on methods that improve the preservation of biological samples. The discovery highlights that in the presence of heterogeneous extracellular ice, endothelial cells exhibit improved attachment and viability after preservation. By uniformly nucleating ice across the microvasculature using ice nucleating agents, the risk of intracellular ice formation can be significantly reduced. This advancement is crucial for enhancing the effectiveness of cryopreservation techniques.
Career Highlights
Reinier is associated with The General Hospital Corporation, where he applies his expertise in cryopreservation. His work is instrumental in advancing medical technologies that rely on the preservation of biological materials. With a patent count of 1 patent, he continues to contribute to the scientific community through his innovative research.
Collaborations
Reinier has collaborated with esteemed colleagues such as Mehmet Toner and Mustafa Korkut Uygun. These partnerships have fostered a collaborative environment that enhances research and development in the field of cryopreservation.
Conclusion
Reinier Johan De Vries is a pioneering inventor whose work in cryopreservation is paving the way for advancements in the preservation of biological samples. His innovative methods and collaborations are set to make a lasting impact in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
